CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) [Phase 2]
Summary
Phase 2 clinical trial update for NasoVAX in patients with early coronavirus infection; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Altimmune, Inc. | Conditions: Coronavirus Infection | Phase 2 | Status: TERMINATED | Results posted: 2022-04-04